| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8715690 | Journal of Dermatological Science | 2018 | 10 Pages |
Abstract
Concentration-response modeling was able to predict the efficacy of doses that were not studied. In psoriasis patients, a dose of 10Â mg (not administered in the study) was predicted to show efficacy similar to 20Â mg. Disease status (PASI score at baseline) as study inclusion criterion has pronounced influence on study outcome.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Andreas Krause, Daniele D'Ambrosio, Jasper Dingemanse,